Next Generation X-Aptamers for Identification of Personalized Biomarkers in Cancer
David G. Gorenstein, Ph.D., University of Texas Health Sciences Center, speaking at Genomics Research 2012.
Genomic and Proteomic Biomarkers for Cardiac and Renal Transplantation: Computational Biomarker Pipeline from Discovery to Clinical Implementation
Dr. Robert McMaster, Professor, University of British Columbia, speaking at Genomics Research 2012.
Signalling Molecules as Proteomic Biomarkers in Brain Tumours
Radu Albulescu talking on behalf of Cristiana Tanase MD, PhD, Victor Babes University of Medicine and Pharmacy, Timisoara, speaking at Molecular Diagnostics Europe 2012.
Towards a Disease-specific Biomarker Signature for Neuromuscular Disorders
Professor Kay Ohlendieck, National University of Ireland, speaking at Molecular Diagnostics Europe 2012.
ESPRIT: High Throughput Screening for Soluble Expression Constructs of Difficult-to-express Proteins
Darren Hart, European Molecular Biology Laboratory, speaking at European Lab Automation 2012
Understanding Cell Transitions at Single-Cell Level
Dr Anders Ståhlberg, University of Gothenburg in Sweden, speaking at Single Cell Analysis Europe 2012.
Too Big for a Small World? Intact Protein Analysis by Nano-UHPLC-MS/MS
Mark Parkin, Kings College London, speaking at European Lab Automation 2012
Capacitive Immunosensors – A Tool for Detection Where Sensitivity of Conventional ELISA is Not Sufficient
Prof. Bo Mattiasson, Lund University, speaking at Advances in Biodetection and Biosensors 2012.
Circulating Tumor Cells: Current State and Future Perspectives
Prof Klaus Pantel, University Medical Center Hamburg-Eppendorf, speaking at Molecular Diagnostics Europe 2012.